Relay Therapeutics's Earnings Outlook
Portfolio Pulse from Benzinga Insights
Relay Therapeutics (NASDAQ:RLAY) is set to release its quarterly earnings report on November 2, 2023. Analysts estimate an earnings per share (EPS) of $-0.83. The company's past performance shows a pattern of EPS misses and minor share price increases. The stock is currently trading at $6.6, down 68.72% over the last 52-week period.
November 01, 2023 | 5:02 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Relay Therapeutics is expected to report an EPS of $-0.83. The stock has been on a downward trend, with a 68.72% decrease over the past year.
The company's stock has been on a downward trend, and with an expected negative EPS, it's likely that the stock price will continue to decrease in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100